Background: Asthma is a chronic inflammatory disorder of the airways with the proven role of Th2 cells in its pathogenesis. The role and characteristic of different subsets of CD4 + cells is much less known.
Methods: Twenty five stable asthmatic and twelve age-matched control subjects were recruited to the study. Bronchoscopy and bronchoalveolar lavage (BAL) were performed in all study subjects. 
Background
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and presence of airway hyperresponsiveness that leads to typical symptoms like recurrent episodes of wheezing, breathlessness, chest tightness and coughing [1] . CD4 + T cells are one of the most important cells in the pathogenesis of airway inflammation in asthma. CD4 + T cells are traditionally divided into Th1 and Th2 subsets based on profile of their cytokines production [2, 3] . Th2 cells, which are characterized by IL-4, IL-5, IL-9 and IL-13 cytokine production, predominate in asthma, whereas Th1 cells producing IFN-γ, IL-2 and TNF have rarely been associated with asthma [2, 3] . More recently new subsets of CD4 + T cells have been described: anti-inflammatory (suppressive) T regulatory (Treg) cells and proinflammatory Th17 cells [2, 3] . CD4 + Treg cells can be divided into natural regulatory T cells (nTreg cells) and inducible or adaptive regulatory T cells (iTreg cells) [4] . nTreg got their name because they are always present in the body and constantly perform their function during normal surveillance of selfantigens [4] . They arise in thymus and leave it fully active, ready to inhibit immunological responses. They constitute the population of long-living cells, resident in peripheral organs and one of their main activities is protection against autoimmunological disorders [4] . The first described marker of these cells was CD25 with a more recent marker of nTreg cells being the constitutively expressed transcription factor Foxp3 [4] . Therefore CD4 + Foxp3 + or CD4 + CD25 + Foxp3 + cells are often regarded as nTreg cells, in spite of the fact that newer markers have also been proposed [5] . However it should be noted that we still lack precise and specific markers of nTreg cells [6] .
iTreg, in contrast to nTreg, obtain their regulatory ability in peripheral tissues. Naïve or mature CD4 + cells are activated by dendritic cells in the secondary lymphoid organs [7] . The main function of iTreg is therefore to counteract excessive or the pathological inflammatory response [7, 8] . There are no good surface markers of iTreg and according to some authors they lack CD25 expression (CD4 + CD25 -cells) [8] whereas others have shown that CD4 + CD25 + iTreg can be generated from naïve CD4 + cells after antigen stimulation in the presence of IL-2 and TGF-β [9] . Furthermore it was shown that TGF-β-induced iTreg cells may express Foxp3 [10] and that Foxp3 + Treg cells are a rich source of TGF-β [11] [12] [13] . These latter cells are also known as Th3 cells. Phenotypic characterization of Th3 cells is very difficult as not all TGF-β-secreting T cells are Th3 cells and not all Th3 cells express Foxp3 [11] [12] [13] .
Tr1 cells are another subset of iTreg cells, which is difficult to study in great details as we still lack precise markers, which could help us to reliably distinguish IL-10-secreting Treg cells from other T cells [14] . Tr1 cells produce IL-10, TGF-β and little or no IL-2, IL-4 and can be sometimes defined as: IL-10
Many studies have demonstrated that IL-10-secreting T cells did not express Foxp3 [15] [16] [17] 
Foxp3
+ cells in BAL increased after allergen provocative test in asthmatic patients [23] .
Th17 cells are a new population of proinflammatory CD4+ T cells which are important during activation of the inflammatory response against bacterial infection for example [24] [25, 26] . Mouse Th17 cells produce large amounts of IL-17, but no IL-4, IFN-γ or Foxp3 and contribute to airway hyper-responsiveness [25, 27] . Several studies showed a possible involvement of Th17 cells in the pathogenesis of asthma. The number of IL-17 positive cells in sputum and BAL as well as the expression of mRNA for IL-17 in sputum cells is increased in asthma [28, 29] . The levels of IL-17 in sputum correlated with hyperresponsiveness to methacholine in asthmatic subjects [30] . Increased levels of IL-17 in sputum were also seen in patients with allergic rhinitis after a nasal allergen challenge [31] . Interestingly, two recent reports showed the opposite results [32, 33] . In the first study an increased expression of IL-17 in the bronchial epithelium was observed in severe asthma but not in mild or moderate asthma [32] whereas increased expression of IL-17 was reported in mild-moderate, but not severe asthma, in the second study [33] .
In this study we isolated CD4 + cells from BAL fluid of asthmatics and age-matched control subjects and after short in vitro stimulation we measured simultaneously the expression of up to six parameters in these cells: 
Materials and methods

Subjects
The study protocol was approved by the ethics committee of the Silesian Medical University. All subjects gave written consent before recruitment to the study. Twenty five stable asthmatic patients with a median age of 50 years (range 24-69 years) were recruited to the study. The inclusion criteria were as follow: the presence of consistent history of asthma together with objective evidence of asthma such as: reversible of airflow obstruction (improvement in FEV 1 greater than 12% or 200 ml 15 minutes after administration of 200 μg of inhaled salbutamol) or airway hyperresponsiveness to methacholine (PC 20 < 8 mg/ml). All patients were treated with inhaled steroids (100-1000 μg/day of fluticasone or equivalent).
The control group consisted of 12 non atopic agematched healthy subjects with a median age of 42 years (range 26-62 years) with no history of any respiratory disease and no evidence of variable airflow obstruction or airway hyperresponsiveness.
The exclusion criteria for both studied groups were respiratory infection or use of oral corticosteroids within 6 weeks before entering the study. Current and ex-smokers of >5 pack-years were also excluded from the study. Subject characteristics are shown in Table 1 .
Bronchoscopy and BAL
The tip of the bronchoscope was wedged into the orifice of a subsegmental bronchus of the middle lobe. Bronchoalveolar lavage was done by sequential installation and aspiration of 8 separate aliquots of 25 mL of warm 0.9% normal saline.
Isolation of CD4+ T cells from BAL fluid
CD4+ T cells were isolated from BAL fluid as previously described [34] . Briefly, BAL cells were spun, washed and resuspended in culture medium (RPMI-1640, 10% [vol/ vol] FCS, 2 mM l-glutamine, 100 IU/mL penicillin, and 100 mg/mL streptomycin). Macrophages were depleted from cells by means of adhesion to plastic plates. Resulting nonadherent cells consisted mainly of lymphocytes, but variable amounts of dead cells, granulocytes, and epithelial cells were also present. Dead cells were eliminated with the Dead Cell Removal Kit (Miltenyi Biotec, Bergisch Gladbach, Germany). Subsequently, CD8+ T cells were removed by using MACS CD8+ MicroBeads (Miltenyi Biotec). Finally CD4+ T cells were isolated by positive selection using MACS CD4+ MicroBeads. The purity of isolated CD4+ T cells were consistently >95% as assessed by FACS.
Flow cytometry
CD4+ cells were washed and stimulated for 6 hours with phorbol 12-myristate 13-acetate (PMA; 10 ng/mL) and ionomycin (400 ng/mL) in the presence of brefeldin A (5 mg/mL). Cells were then washed twice in wash buffer, fixed in cold 4% formaldehyde, washed in PBS, and frozen at -70°C for later use as described previously [34] . Subsequently, cells were thawed, washed, permeabilized, washed again and stained with a cocktail of antibodies (described in details in Table 2 ) or respective mouse isotype control antibodies for 30 minutes at room temperature in the dark (all antibodies were from BD Pharmingen, Oxford, UK with exception for PE-labeled anti-TGF-β purchased at IQ Products, Groningen, The Netherlands). After being washed twice, the cells were resuspended in 1% formaldehyde in PBS and analyzed within 24 hours by means of six-colour flow cytometry (FACSAria flow cytometer, BD Biosciences). Representative plots of flow cytometric analysis were shown in Additional file 1.
Statistical analysis
Statistical analysis was performed using software packages (GraphPad Prism 5.0; Statistica 9.0). Data are presented as median (95% confidence intervals) except where stated. A Gaussian distribution was tested with D' Agostino and Pearson omnibus normality test. Between-group comparisons were assessed using a Mann-Whitney U test for non-parametric data. Regression analysis was performed using the Spearman rank correlation test. P values of less than 0.05 were accepted as significant.
Results
BAL cell characterization
The percentage of eosinophils in BAL fluid of asthmatics was significantly higher compared to control subjects (p < 0.01). Full characterisation of BAL cells is provided in Table 3 .
Percentage of BAL CD4
+ cells expressing and co-expressing Foxp3 in healthy subjects [1.4% (0.8-4.0%), Figure 1A ; P = 0.03].
In contract, there was no significant differences between asthma and control groups in the percentage of CD4 Figure 1C ; P = 0.004] and CD25 [51.3% (11.9-88.1%) vs 35.1% (13.2-72.5%); Figure 1D ; P = 0.04). In contrast, no significant difference between the studied groups were observed for the Figure 2A ; P = 0.004] and TNF-α [54.6% (10.4-79.5%) vs 40.7% Table 3 Characteristics of BAL cells from the study population Figure 3B ; P = 0.047] were significantly increased in asthmatics compared with that seen in healthy subjects. No significant differences between the two groups were observed for the percentage of CD4 Figure 3C 
Discussion
In this study we analyzed the incidence of different subsets of CD4 + T cells together with the co-expression of various cytokines in BAL fluid of asthma patients and healthy subjects. We found that in BAL fluid of patients with chronic asthma have a decreased population of + did not differ between the two groups studied.
Asthma is an inflammatory disease of a peripheral organ, the lung, so the involvement of locally-induced iTreg cells instead of nTreg cells in the pathogenesis of this disease seems to be more probable. The decreased population of Th3 iTreg cells may, therefore, contribute to the presence of airway inflammation and to asthma progression since there is a correlation between the percentage of CD4 + Foxp3 + TGF-β + cells and FEV 1 . Although several studies have previously shown the importance of IL-17 and IL-17 producing cells in asthma pathogenesis our study is, to our knowledge, the first to show using flow cytometry and intracellular cytokine staining that the percentage of CD4 + IL-17 + cells in BAL fluid of asthma patients is increased. Th17 cells are known inducers of neutrophilic inflammation as they stimulate other cells (e.g. epithelial cells) to produce IL-8/CXCL8, which is one of the most potent neutrophil chemoatractants [2] . In this study we showed that CD4 
